EFFECTIVE MAINTENANCE OF RESPONSE IN ATOPIC DERMATITIS PATIENTS AFTER SWITCHING FROM DUPILUMAB TO ABROCITINIB (JADE-EXTEND)

Authors
Category Primary study
JournalAnnals of Allergy, Asthma and Immunology
Year 2020
This article has no abstract
Epistemonikos ID: f1201eae2b863b913a958fd5a930e079fa6e3493
First added on: Feb 12, 2025